ea0044p110 | Diabetes and Cardiovascular | SFEBES2016
Azharian Sahar
, Neal Matthew
, Kyrou Iannos
, Piya Milan
, Kumar Sudesh
, Covington James
, McTernan Philip
, Vrbikova J
, Hainer V
, Sramkova P
, Fried M
Background: Human obesity can significantly contribute to hypertension risk, often referred to as the ‘silent killer’, although targeting whom with weight gain becomes clinically hypertensive is unclear. Whilst therapeutic intervention such as bariatric surgery can mitigate both obesity and hypertension, it is not the most suitable solution for all patients. Therefore an early biomarker detection system to assess hypertension in subjects with weight gain could reduce...